Pfizer Authorization for 12-15 yrs

The Pfizer vaccine is now available in Colorado to anyone 12 years of age and older. The dosage and dosing regimen of the vaccine (two doses, three weeks apart) will be the same as in those 16+ years old. The Moderna and Johnson & Johnson vaccines continue to be available only to adults 18 years of age and older.

Schedule a vaccination appointment here.

On May 12, CDC’s Advisory Committee on Immunization Practices (ACIP) recommended the use of Pfizer COVID-19 vaccine for children aged 12 to 15. The recommendation comes after the Food and Drug Administration (FDA) amended the vaccine’s Emergency Use Authorization (EUA) to include adolescents 12 through 15 years of age.

While children are less likely to get seriously sick or die from COVID-19, they are still at risk, and can spread the virus to others. Vaccinating tweens and teens — especially before summer camps and in-person schooling in the fall — will help us in our fight to curb the pandemic.

In a clinical trial, the Pfizer vaccine was shown to be safe and effective among people age 12-15.

  • The trial included 2,260 children ages 12-15 years old in the U.S., about half of whom got Pfizer’s COVID-19 vaccine.
  • There were 18 cases of COVID-19 in the placebo (unvaccinated) group and none in the vaccinated group. The vaccine showed 100% efficacy in this trial.
  • Side effects were about the same as those seen in people age 16 and older.

Pfizer’s amended EUA can be found on the FDA’s website: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine

Anyone 11 years old or younger should not get a COVID-19 vaccine unless they are enrolled in a clinical trial.

The COVID-19 vaccination campaign is ongoing in the US and around the world. Dr. Evan Anderson, Professor of Pediatrics and Medicine at Emory University School of Medicine,  provides an update regarding vaccinating children and pregnant women. He also discusses potential concerns related to the new SARS-CoV-2 variants and steps taken to address them. See the research and data in this webinar: COVID-19 Webinar: Vaccine Update - Pregnant Women, Children and Variants.